Clinical Trials Sponsored by Eye Therapies, LLC

Total 66 results

Eye Therapies, LLC

Completed

Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension

Glaucoma and Ocular Hypertension

United States
Eye Therapies, LLC

Completed

Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

Ocular Redness

United States
Eye Therapies, LLC
ORA, Inc.

Completed

A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)

Allergic Conjunctivitis

United States
Hexagon Therapies, LLC

Unknown

Quality of Life Improvements With Cord Blood Plasma

Aging
pico-tesla Magnetic Therapies, LLC

Completed

Study of Magnetic Fields for Treatment of Parkinson's Disease

Parkinson's Disease

United States
pico-tesla Magnetic Therapies, LLC

Terminated

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Type 2 Diabetes

United States
pico-tesla Magnetic Therapies, LLC

Unknown

Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease

Quality of Life | Parkinson's Disease

United States
pico-tesla Magnetic Therapies, LLC

Unknown

Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease

Alzheimer's Dementia

United States
pico-tesla Magnetic Therapies, LLC

Completed

Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)

Parkinson's Disease
pico-tesla Magnetic Therapies, LLC

Completed

Evaluation of Magnetic Fields to Treat Fibromyalgia

Fibromyalgia
pico-tesla Magnetic Therapies, LLC

Withdrawn

Study of Magnetic Fields to Treat Alzheimer's Disease

Alzheimer's Disease

United States
pico-tesla Magnetic Therapies, LLC

Completed

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Type II Diabetes Mellitus

United States
pico-tesla Magnetic Therapies, LLC

Withdrawn

Low Level Magnetic Fields for the Treatment of Osteoarthritis of the Hip

Osteoarthritis of the Hip

United States
Neuro-Eye Diagnostic Systems, LLC
Neuro-ophthalmology of Texas PLLC

Enrolling by invitation

Implementation of the NEDS EyeCTester App

Macular Disease | Visual Pathway Disorder | Optic Nerve Disease

United States
Wills Eye
Merck Sharp & Dohme LLC

Completed

Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines?

Open Angle Glaucoma

United States
ChromoLogic, LLC
UW Medicine Eye Institute

Completed

Flare Photometry in Uveitis Patients

Uveitis

United States
Panhandle Eye Group, LLP

Completed

Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV

Diabetic Retinopathy

Mexico
Wills Eye
Merck Sharp & Dohme LLC

Completed

How Has Glaucoma Affected Your Quality of Life?

Quality of Life | Glaucoma

United States
Panhandle Eye Group, LLP

Recruiting

Panretinal Photocoagulation During Vitrectomy for Diabetic Vitreous Hemorrhage

Diabetic Vitreous Hemorrhage

Mexico
Panhandle Eye Group, LLP

Suspended

Intracameral Antibiotic Safety Study

Endophthalmitis | Cataract Surgery | Phacoemulsification | Vancomycin | Intracameral Antibiotics | Moxifloxacin

United States
AEYE Health LLC

Completed

Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus Images

Diabetes Mellitus | Diabetic Retinopathy

United States
AEYE Health LLC

Completed

Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images

Diabetes Mellitus | Diabetic Retinopathy

United States
LEC Eye Centre
Alcon Research

Completed

Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

Cataract Senile | Intraocular Lens Complication

Malaysia
Calm Water Therapeutics LLC
Andover Research Eye Institute

Completed

Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops

Dry Eye Disease

United States
Iqbal Ahmed
OMNI Medical Services, LLC

Terminated

Standalone OMNI Surgical System for Open-angle Glaucoma (OMNIgl)

Open Angle Glaucoma

Canada
Johns Hopkins University
National Eye Institute (NEI); Visionize, LLC

Completed

Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System (eLVES)

Low Vision

United States
The Emmes Company, LLC
National Eye Institute (NEI); Allergan

Completed

The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study (SCORE)

Retinal Vein Occlusion | Macular Edema, Cystoid

United States
Philadelphia Eye Associates
Merck Sharp & Dohme LLC; Thomas Jefferson University

Withdrawn

Study to Determine the Effect of Azasite on Corneal Surface Irregularity

Meibomian Gland Dysfunction

United States
Johns Hopkins University
National Eye Institute (NEI); Results Group LLC

Terminated

Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)

Age-related Macular Degeneration

United States
National Eye Institute (NEI)
The Emmes Company, LLC; Santen Inc.

Terminated

Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy (Sirolimus)

Geographic Atrophy

United States
Mun Wai Lee
Santen Oy

Recruiting

Dry Eye Management With 3% Diquafosol Before and After Cataract Surgery

Dry Eye

Malaysia
Sloan W. Rush, MD

Completed

Immediate Simultaneous Bilateral Cataract Surgery (ISBCS)

Bilateral Cataract

United States
Sloan W. Rush, MD

Completed

Corneal Epithelial Stem Cells and Dry Eye Disease

Ocular Inflammation | Dry Eye | Dry Eye Syndromes | Ocular Surface Disease | Blepharitis | Ocular Discomfort

United States
Sloan W. Rush, MD

Completed

Aquatic Therapy and Autism Spectrum Disorders (AT&ASD)

Autism Spectrum Disorder

United States
Inoveon Corporation
National Eye Institute (NEI); LKC Technologies, Inc.

Completed

RETeval Study for Diabetic Retinopathy

Diabetic Retinopathy

United States
TearLab Corporation
Abbott Medical Optics; TLC Laser Eye Center

Completed

TearLab Refractive Surgery Dry Eye Study

Dry Eye Syndromes

United States
Massachusetts General Hospital
Merck Sharp & Dohme LLC; Massachusetts Eye and Ear Infirmary

Terminated

An Open-label Study to Identify Molecular Markers of Steroid Resistance (MERK2)

Nasal Polyps

United States
The Emmes Company, LLC
National Eye Institute (NEI); University of California, Davis

Active, not recruiting

Treatment of Central Retinal Vein Occlusion Using Stem Cells Study (TRUST)

Central Retinal Vein Occlusion

United States
Kevin Barber
Alcon Research; Eric Rosenberg, D.O.,M.Sc.Eng.

Completed

Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.

Cataract

United States
Aeon Astron Europe B.V.
The New York Eye & Ear Infirmary; Robert Ritch, MD, LLC.

Completed

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery (MCToCM)

Glaucoma

United States
TcLand Expression S.A.
Premier Research Group plc; Theradis pharma; Medpharmgene, Inc.

Terminated

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (PRINT)

Rheumatoid Arthritis

Canada, France, Hungary, Italy, Lithuania, Romania, Slovakia, Spain
Luxa Biotechnology, LLC
National Eye Institute (NEI); National Institutes of Health (NIH); Regenerative...

Recruiting

Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)

Dry Age-related Macular Degeneration

United States
National Eye Institute (NEI)
The Emmes Company, LLC

Completed

Topical Interferon Gamma-1b for Central Serous Chorioretinopathy

Macular Disease | Retinal Disease

United States
National Eye Institute (NEI)
The Emmes Company, LLC

Completed

Ranibizumab and Bevacizumab for Diabetic Macular Edema

Diabetic Macular Edema

United States, United Kingdom
National Eye Institute (NEI)
The Emmes Company, LLC

Completed

Dextromethorphan for Diabetic Macular Edema (MiDME2)

Diabetic Macular Edema

United States
National Eye Institute (NEI)
The Emmes Company, LLC

Terminated

Finasteride for Chronic Central Serous Chorioretinopathy

Retinal Disease

United States
National Eye Institute (NEI)
The Emmes Company, LLC

Completed

Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa

Retinitis Pigmentosa

United States
National Eye Institute (NEI)
The Emmes Company, LLC

Completed

Gevokizumab for Active Scleritis

Scleritis

United States
National Eye Institute (NEI)
The Emmes Company, LLC

Terminated

A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients (GVHD ASED)

Graft vs Host Disease

United States
National Eye Institute (NEI)
The Emmes Company, LLC

Completed

A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema

Diabetic Macular Edema

United States

Clinical Trials Sponsored by Eye Therapies, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations